These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 30132837)
21. Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia. Hola MAM; Ali MAM; ElNahass Y; Salem TAE; Mohamed MR Int J Lab Hematol; 2021 Aug; 43(4):732-742. PubMed ID: 34129278 [TBL] [Abstract][Full Text] [Related]
22. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia. Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of CTNNB1: Clinical implication in Chinese de novo acute myeloid leukemia. Li XX; Guo H; Zhou JD; Wu DH; Ma JC; Wen XM; Zhang W; Xu ZJ; Lin J; Jun Q Pathol Res Pract; 2018 Mar; 214(3):361-367. PubMed ID: 29496308 [TBL] [Abstract][Full Text] [Related]
24. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331 [TBL] [Abstract][Full Text] [Related]
25. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia. Zhang YY; Yao DM; Zhu XW; Zhou JD; Ma JC; Yang J; Wen XM; Guo H; Lin J; Qian J Leuk Res; 2015 Oct; 39(10):1041-7. PubMed ID: 26242829 [TBL] [Abstract][Full Text] [Related]
26. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia. Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222 [TBL] [Abstract][Full Text] [Related]
27. Expression characteristic of Zhang W; Zhang L; Qian J; Lin J; Chen Q; Yuan Q; Zhou J; Zhang T; Shi J; Zhou H Bioengineered; 2021 Dec; 12(2):11987-12002. PubMed ID: 34787059 [No Abstract] [Full Text] [Related]
28. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients. Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276 [TBL] [Abstract][Full Text] [Related]
29. HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis. Hao S; Shao Z Int J Clin Exp Pathol; 2015; 8(6):7223-8. PubMed ID: 26261618 [TBL] [Abstract][Full Text] [Related]
30. HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia. Zhou X; Liang S; Zhan Q; Yang L; Chi J; Wang L Cell Death Dis; 2020 Jun; 11(6):492. PubMed ID: 32606327 [TBL] [Abstract][Full Text] [Related]
31. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients. Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049 [TBL] [Abstract][Full Text] [Related]
32. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia. Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040 [TBL] [Abstract][Full Text] [Related]
33. Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia. Zhang TJ; Xu ZJ; Gu Y; Ma JC; Wen XM; Zhang W; Deng ZQ; Qian J; Lin J; Zhou JD Clin Epigenetics; 2021 Jan; 13(1):16. PubMed ID: 33485366 [TBL] [Abstract][Full Text] [Related]
34. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia. Tian Y; Huang Z; Wang Z; Yin C; Zhou L; Zhang L; Huang K; Zhou H; Jiang X; Li J; Liao L; Yang M; Meng F PLoS One; 2014; 9(1):e84150. PubMed ID: 24416201 [TBL] [Abstract][Full Text] [Related]
35. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer. Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931 [TBL] [Abstract][Full Text] [Related]
36. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia. Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia. Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078 [TBL] [Abstract][Full Text] [Related]
38. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176 [TBL] [Abstract][Full Text] [Related]
39. Correlation of long non-coding RNA taurine-upregulated gene 1 with disease conditions and prognosis, as well as its effect on cell activities in acute myeloid leukemia. Qin J; Bao H; Li H Cancer Biomark; 2018; 23(4):569-577. PubMed ID: 30452403 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of HOXB4 in de novo acute myeloid leukemia. Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]